Option chain shows key data for Kairous Acquisition Corp's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kairous Acquisition Corp.

Kairous Acquisition Corp (NASDAQ:KACLW) Stock, Option Chain

Kairous Acquisition Corp Ltd is a blank check company.

Kairous Acquisition Corp. Limited - Warrants

Kairous Acquisition Corp Ltd

WIIM

ASNS

Actelis Networks shares are trading higher after the company announced two expansion orders from the Washington DC Department of Transportation.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585aa876b5a482000151d0ee/kevin-grundy">Exane BNP Paribas analyst Kevin Grundy</a> initiated coverage on Constellation Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) with a Neutral rating and announced a price target of $261. Constellation Brands shares closed at $239.66 on Friday. <a href="https://www.benzinga.com/quote/STZ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>TD Cowen analyst Joseph Thome initiated coverage on Viridian Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRDN#NASDAQ">VRDN</a>) with a Buy rating. Viridian Therapeutics shares closed at $20.20 on Friday. <a href="https://www.benzinga.com/quote/VRDN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity analyst Edward Nash initiated coverage on Apogee Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>) with a Buy rating and announced a price target of $89. Apogee Therapeutics shares closed at $43.46 on Friday. <a href="https://www.benzinga.com/quote/APGE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS analyst Timothy Arcuri initiated coverage on Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Buy rating and announced a price target of $160. ARM shares closed at $135.99 on Friday. <a href="https://www.benzinga.com/quote/ARM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co. analyst Mitchell Kapoor initiated coverage on Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Sell rating and announced a price target of $80. Sarepta Therapeutics shares closed at $114.23 on Friday. <a href="https://www.benzinga.com/quote/srpt/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SRPT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="621" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25085724/image-268-1024x621.png" alt="" class="wp-image-663414" style="width:645px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25085724/image-268-1024x621.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25085724/image-268-300x182.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25085724/image-268-768x466.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25085724/image-268.png 1085w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42137942/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

APGE

SRPT

VRDN

This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday

AI, and specifically Generative AI with its ability for predictive analytics, is becoming a critical component of digital transformation and future business growth in almost all industries. Enterprise-grade data networks such as Verizon's will be instrumental in these processes, and Verizon continues to advance its network components to deliver on the promises of AI. In a recent trial in Boston, Verizon moved 1.6 Tb/s of data in its live fiber network on a single-carrier wavelength using <a href="https://www.globenewswire.com/Tracker?data=jEsaVB2cRTvK3bQqbyTHO0WZ7rGV6Qu4UgnYeJ6SxtN_4W-BZBlfjdBh34O8xVoBzGPGUPnsWwnc2VeDBgK_z1squs4lkiPD43cyhJp89LQHhxkBFwp9ztWYfoSj-5wBQ9yW8hUMf1OqKpN5YKbd3ikA1NCwioZaXHbWOK3yEDHTYxItAdo3NtR3o8Nt7Iy92cwJCAoob-856xQgiZwJgajud3S04kTfXQkZSmLilUzw715k6KbeGmzs4Niwfvn5BvPJK6e6SnUpZZVZzwrb1CyAM8twHYwLd50J5gRFFfViQ0DPUEFiI2pCngp3DkkEazk78a8DzBtkqjqNIgWEIebtCJjBdLpuE7OgwpZf46YBDAVuWNSbNmUNjjF66_fcqQUGq83OZsxHYLl7HltBVTcvceuz_mdGUXz-qnHxSScM1hdJoLlIqChXTjtZP6CgKqgoYpdbXAuJwZD1kGcBJcglFZ7w1i8RZteTvxF0iBiosrsQl8ru3ys_siIIHANXl-FGxMnX5RTQAdO-DYtOJA==">Ciena's</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) WaveLogic 6 Extreme (<a href="https://www.globenewswire.com/Tracker?data=KDfXHnLxFL6Ym-4uoiVOOK5wA1UpvHeruhAV72AO5TPZd3MSkVRXKc6u9vX1BYo-awwRn0n1j7u_Cg4iUJtKEoH_WTCjIrUMvZ7Yt2Yhj3VqQ05XqLRFywz0SfuWD7LcPwsTKpQAKs8ywklSgA5lM4nK-iGxrWkkaJkvmMHgfE-_gEzaXL64H21u2SzPjS1VGagX_QKjEu6rKviUFDuX6tk2iCJu2jR6sh3HQY5oSFai7hJQs2FMy9mnSZFlb484ngZAcA7bws7wXeBrV9SajMAcPCLzQt8M9yhN5YedR8I9Gk8pPUaw9ohwWR7UGbZpuThDbBIjzs3RFqgpyr-tv0_AIpYwhX8z0n-z6K1qDSDyWeUctrxZj5ShKn_xbSJSvaKt51MPdF2yQX3IC7Q2b4TVC8ANKNjwSXKxBzj0GLSUiBDr_FhQqtPjh9pXeQ-1A-_NE-lY0-3-QFlmne2ypuORdXuI7UE-pyIhb8duHONRkG8m1BWRGKJ0FRaxGTwosvWOotZZ0KqlHwweHsycvaNFhoVXK7sKkc1vpd607A8=">WL6e</a>) coherent optical solution. This next generation technology allows data traveling across Verizon's fiber network to travel farther and faster, leading to a better customer experience. In addition, the upgrade to this new equipment will result in higher reliability and significant energy savings in that portion of the fiber network.

CIEN

Verizon Advances Its Fiber Network For AI Workloads Using Ciena's WaveLogic 6, A Next Generation Technology That Allows Data Traveling Across Verizon's Fiber Network To Travel Farther And Faster

Mizuho analyst Ben Chaiken downgrades Red Rock Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>) from Outperform to Neutral and lowers the price target from $57 to $44.

Downgrades

Price Target

Mizuho Downgrades Red Rock Resorts to Neutral, Lowers Price Target to $44

With just six weeks left in 2024, Senate Majority Leader <a href="https://www.benzinga.com/topic/chuck-schumer">Chuck Schumer</a> (D-NY) faces mounting criticism for failing to deliver on his <a href="https://www.benzinga.com/markets/cannabis/24/03/37526202/chuck-schumer-senate-will-work-very-hard-to-pass-cannabis-banking-bill-before-upcoming-elections">long-standing promise</a> of achieving cannabis banking reform. Now, he&#8217;s mounting a Hail Mary effort to get it across the finish line before the term ends.
Senators on Capitol <a href="https://login.politicopro.com/?redirect=https://subscriber.politicopro.com/newsletter/2024/11/weed-banking-hopes-rise-again-00190071">told</a> Politico they &#8220;still have hopes the cannabis banking bill can get done in the lame duck, despite the odds.&#8221; 
What Happened: Schumer, who brought the <a href="https://www.benzinga.com/topic/secure-and-fair-enforcement-safe-banking-act" target="_blank" rel="noreferrer noopener">Secure and Fair Enforcement Regulation (SAFER) Banking Act</a> (SAFER) to a <a href="https://www.benzinga.com/markets/cannabis/23/09/34929327/breaking-senate-committee-approves-cannabis-banking-reform-in-historic-vote">committee hearing</a> in September 2023, had intended to advance the bill by attaching it to must-pass legislation before the midterms. However, despite his vocal support, he did not call the bill for a full Senate vote, citing insufficient Republican backing to overcome filibuster rules. This hesitation, coupled with Democrats&#8217; shifting priorities after this month's <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">Republican electoral surge,</a> has all but killed hopes for cannabis banking reform during the lame-duck session.
And now, Senate Democrats are scrambling to address more immediate legislative tasks, including passing budget bills to avoid a looming <a href="https://www.benzinga.com/news/24/09/40931809/house-republicans-reject-their-own-funding-bill-as-government-shutdown-looms-mike-johnson-says-we-ha">Dec. 20 government shutdown</a> and finalizing judicial appointments before relinquishing control in January.
<h2 class="wp-block-heading">High Stakes As GOP Takes Congress</h2>
Senator <a href="https://www.benzinga.com/politics/24/11/41950681/trump-once-said-political-career-over-about-john-thune-now-senate-majority-leader-working-with-him-to-pass-gop-agenda">John Thune</a> of South Dakota who opposes marijuana legalization, is set to replace Sen. <a href="https://www.benzinga.com/topic/mitch-mcconnell" target="_blank" rel="noreferrer noopener">Mitch McConnell</a> as Senate majority leader. With Thune and conservative House Speaker Mike Johnson at the helm, the path to cannabis reform becomes even narrower. Johnson <a href="https://www.benzinga.com/markets/cannabis/23/10/35428675/buzz-kill-mike-johnsons-election-as-new-house-speaker-does-not-bode-well-for-cannabis-legalizati">has consistently voted against</a> most cannabis-related legislation, including banking reform.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41982165/new-gop-senate-leader-john-thune-opposes-marijuana-legalization-implications-for-banking-access-and-more">New GOP Senate Leader John Thune Opposes Marijuana Legalization: Implications For Banking Access And More</a>
Critics argue that Democrats, despite their rhetoric or best efforts, have fallen short of delivering substantive cannabis reform. Their missed opportunity leaves the industry bracing for continued financial instability.
Meanwhile, <a href="https://www.benzinga.com/24/11/42125955/cannabis-stocks-feel-the-burn-as-gaetz-bows-out-msos-in-focus">cannabis stocks tanked</a> last Thursday after pro-marijuana&nbsp;Matt Gaetz&nbsp;<a href="https://www.benzinga.com/24/11/42119848/matt-gaetz-withdraws-name-from-ag-nomination-calls-sex-trafficking-controversy-a-distraction" target="_blank" rel="noreferrer noopener">withdrew his nomination</a>&nbsp;for U.S. Attorney General and was replaced by the far less weed-friendly nominee Pam Bondi, a close associate of President-elect <a href="https://www.benzinga.com/topic/donald-trump">Donald Trump</a>.
<h2 class="wp-block-heading">Looking Ahead</h2>
As the likelihood of meaningful cannabis reform fades under the outgoing Democratic administration, advocates are left with no choice but to turn to the incoming Republican leadership, hoping they embrace the stance candidate Donald Trump <a href="https://www.benzinga.com/markets/cannabis/24/08/40561136/trump-dislikes-having-people-in-jail-for-cannabis-will-he-legalize-if-elected-or-just-trying-to-">expressed back in August</a> at his Mar-a-Lago residence. 
&#8220;As we legalize it, I start to agree a lot more because it&#8217;s being legalized all over the country,&#8221; the president-elect said.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform">Trump&#8217;s Pick for Attorney General Is No Matt Gaetz When It Comes To Cannabis Reform</a></li>
</ul>
Photo via Shutterstock

Cannabis

Government

Politics

Legal

GOP Takeover, Trump's Return Vs. Chuck Schumer's Last-Ditch Cannabis Banking Reform Push

CMAX

CareMax shares are trading lower after the company announced restructuring amidst its bankruptcy and delisting challenges.

Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) shares are trading higher after the company reported better-than-expected <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42159938/bath-body-works-reports-third-quarter-2024-results" rel="noreferrer noopener">third-quarter results and raised its 2024 outlook</a>.
BBWI&#8217;s third-quarter adjusted earnings per share of 49 cents, beating the analyst consensus of 47 cents.
Quarterly sales of $1.610 billion, a growth of 3.1% year-over-year, above the street view of $1.579 billion.
The gross margin was 43.5%, down 20 bps YoY, and the operating margin was 13.5% compared to 14.2% YoY.
Related: <a target="_blank" href="https://www.benzinga.com/24/11/42131172/bath-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts" rel="noreferrer noopener">Bath &amp; Body Works Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a>
&#8220;Innovation across our core products, adjacencies, and collaborations is resonating with both new and existing customers supported by the investments we have made in marketing and technology. We are capitalizing on our agile business model and predominantly U.S.-based supply chain, and we believe we are well-positioned to navigate a volatile retail environment and shorter holiday calendar,&#8221; commented Gina Boswell, CEO of Bath &amp; Body Works.
Net cash used for operating activities year-to-date totaled $69 million, compared to cash provided of $28 million a year ago.
Bath &amp; Body Works exited the quarter with cash and equivalents of $191 million. The company&#8217;s inventories as of quarter end totaled $1.178 billion, with long-term debt of $3.88 billion.
Bath &amp; Body Works had recently declared a regular quarterly dividend of&nbsp;$0.20&nbsp;per share, payable on December 6, 2024, to shareholders of record at the close of <a target="_blank" href="https://www.benzinga.com//node/41842833" rel="noreferrer noopener">business on November 22, 2024.</a>
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/downgrades/24/11/41855430/bath-body-works-stock-downgraded-due-to-this-risk-details" rel="noreferrer noopener">Bath &amp; Body Works Stock Downgraded Due To This Risk: Details</a>
Q4 Outlook: Bath &amp; Body Works projects net sales to decline of 6.5% to a decline of 4.5% year-over-year, reflecting a 500-basis-point headwind from a shifted fiscal calendar. Earnings per share are expected to be between $1.94 and $2.07, versus the $1.98 consensus.
2024 Outlook: The company raised fiscal 2024 guidance and now expects net sales to decline 2.5% &#8211; 1.7% (prior view: decline of 4% &#8211; 2%), including a 100-basis-point headwind from the 53rd week in 2023. Adjusted earnings per share are projected at $3.15&nbsp;&#8211; $3.28 <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">(prior view $3.06&nbsp;&#8211; $3.26) versus the $3.18 consensus.</a>
Price Action: BBWI shares are trading higher by 19.2% at $36.61 premarket at the last check Monday.
Image via Unsplash

Earnings

Equities

Guidance

Dividends

Movers

BBWI

Bath & Body Works Delivers Growth Amid Challenges, Beats Q3 Expectations And Lifts 2024 Projections

STKH

UMAMI Bioworks And Steakholder Foods Partner To Scale 3D-Printed Fish Fillets For Global Commercialization

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer recommended buying BHP Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>), adding that it's a &#8220;very <a href="https://www.benzinga.com/24/11/42084529/bhp-unveils-14-billion-capex-for-chilean-copper-operations">well-run&#8221; company.</a>
On Nov. 20, BHP announced plans to invest up to $14 billion to enhance its copper production in Chile, as revealed during a three-day site tour of its operations. This substantial capital expenditure aims to secure the long-term future of its assets in the region and support the growing global demand for copper.
Cramer said Diamondback Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) is a buy.
On Nov. 4, Diamondback Energy reported quarterly earnings of $3.38 per share, which missed the analyst consensus estimate of $3.99 per share. The company reported quarterly sales of $2.65 billion which beat the analyst consensus estimate of $2.44 billion.
When asked about AMC Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>), he said, &#8220;If it gets to six, I want you to sell it. Period. End of story.&#8221;
On Nov. 12, the company disclosed a debt retirement move in a SEC filing. The company said it entered into a series of privately negotiated agreements to retire $24.22 million in unsecured debt through 5.75% subordinated notes due 2025 <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41952040/amc-entertainment-shares-are-on-the-rise-today-whats-going-on">between Nov. 8 and Nov. 12</a>.
Copart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) is a &#8220;remarkable&#8221; company, Cramer said. &#8220;I need to see a pullback in Copart.&#8221;
On Nov. 21, Copart reported better-than-expected sales results for the first quarter.
Price Action:
<ul>
<li>BHP Group shares gained 0.7% to settle at $52.36 on Friday.</li>
<li>Diamondback Energy shares gained 1.4% to close at $185.29.</li>
<li>AMC Entertainment shares gained 1.3% to close at $4.55.</li>
<li>Copart shares jumped 10.2% to settle at $62.70 during the session.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42137942/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

Long Ideas

Media

CPRT

FANG

Jim Cramer: Copart Is 'Remarkable,' BHP Is 'Well-Run,' Buy This Energy Stock

Contracts

Actelis Networks Announces Two Expansion Orders For The Washington DC Department Of Transportation, Terms Not Disclosed

TDOC

Teladoc Health Launches New AI-Capabilities To Enhance Virtual Sitter Solution To Improve Patient Safety

ONCT

Oncternal Therapeutics shares are trading lowers after the company announced that NASDAQ plans to delist its stock.

APLM

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

UFPI

UFP Packaging Opens Facility In Newnan, GA

ICCT

iCoreConnect Expands Partnership With Maryland State Dental Association To Include Its Full Platform Of Cloud-based Software And Technology Solutions.

Lakeside Holding's Hupan Pharmaceutical Partners With  Sinopharm Group Hubei.

TD Cowen analyst Andrew Charles maintains Domino's Pizza (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) with a Buy and raises the price target from $475 to $515.

TD Cowen Maintains Buy on Domino's Pizza, Raises Price Target to $515

Goldman Sachs analyst Robert Cox downgrades Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) from Buy to Neutral and maintains the price target from $313 to $313.

Goldman Sachs Downgrades Arthur J. Gallagher to Neutral, Maintains Price Target to $313

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Wedbush analyst Daniel Ives upgraded the rating for Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) from Neutral to Outperform and announced a $190 price target. Snowflake shares closed at $167.44 on Friday. <a href="https://www.benzinga.com/quote/SNOW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>DA Davidson analyst Linda Bolton Weiser upgraded The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) from Neutral to Buy and raised the price target from $160 to $209. Procter &amp; Gamble shares closed at $176.28 on Friday. <a href="https://www.benzinga.com/quote/PG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wolfe Research analyst Andrew Rosivach upgraded the rating for Jones Lang LaSalle Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JLL#NYSE">JLL</a>) from Peer Perform to Outperform and announced a $353 price target. Jones Lang LaSalle shares closed at $263.27 on Friday. <a href="https://www.benzinga.com/quote/JLL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup analyst Keith Horowitz upgraded U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) from Neutral to Buy and boosted the price target from $49 to $65. U.S. Bancorp shares closed at $52.49 on Friday. <a href="https://www.benzinga.com/quote/USB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs analyst Robert Cox upgraded the rating for W. R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) from Neutral to Buy and announced a $69 price target. WR Berkley shares closed at $62.27 on Friday. <a href="https://www.benzinga.com/quote/WRB/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SNOW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25084918/image-267-1024x586.png" alt="" class="wp-image-663381" style="width:637px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25084918/image-267-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25084918/image-267-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25084918/image-267-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25084918/image-267.png 1121w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42137942/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

Upgrades

SNOW

This Snowflake Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) with a Buy and maintains $10 price target.

Reiteration

LGVN

HC Wainwright & Co. Reiterates Buy on Longeveron, Maintains $10 Price Target

Kairous Acquisition Corp

Comments

Kairous Acquisition Corp

Kairous Acquisition Corp (KACLW) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga